Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
| Author | |
|---|---|
| Abstract |
:
Treatment of newly diagnosed advanced-stage ovarian cancer typically involves cytoreductive surgery and systemic chemotherapy. We conducted a trial to investigate whether the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to interval cytoreductive surgery would improve outcomes among patients who were receiving neoadjuvant chemotherapy for stage III epithelial ovarian cancer. |
| Year of Publication |
:
2018
|
| Journal |
:
The New England journal of medicine
|
| Volume |
:
378
|
| Issue |
:
3
|
| Number of Pages |
:
230-240
|
| Date Published |
:
2018
|
| ISSN Number |
:
0028-4793
|
| URL |
:
http://www.nejm.org/doi/abs/10.1056/NEJMoa1708618?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
|
| DOI |
:
10.1056/NEJMoa1708618
|
| Short Title |
:
N Engl J Med
|
| Download citation |
